Akebia Therapeutics | AKBA - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amgen USD 1.87B 271M 2026-06
Ardelyx USD 4.81M 6.04M 2026-03
Astellas Pharma JPY 158.38B 28.94B 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 4.54B 692M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Celltrion KRW 92.83B 14.59B 2026-03
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Exelixis USD 20.66M 704K 2026-06
Fresenius Medical Care EUR 3.55B 117.58M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 8B 67M 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Moderna USD 93M 862M 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pharma Mar EUR 4.73M 1.08M 2026-06
Prothena USD 28.94M 11.58M 2025-09
PTC Therapeutics USD 39.61M 23.31M 2026-03
Qiagen NV USD 196.45M 13.73M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Tilray USD 164.37M 8.41M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03